Evidence map›Paper›PMID 39838458›Full record

ArticleBMC biology2025

Co-isolation of human donor eye cells and development of oncogene-mutated melanocytes to study uveal melanoma.

Yunxi Chen, Eva Jin, Mohamed Abdouh, Éric Bonneil, Daniel Alexander Jimenez Cruz, Thupten Tsering, Qianqian Zhou, Aurélie Fuentes-Rodriguez, Alexandra Bartolomucci, Alicia Goyeneche and 3 more

Abstract read
In one paragraph

Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. The latestExpert opinion on drug discovery · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yunxi ChenCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Eva JinCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Mohamed AbdouhCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Éric BonneilInstitute for Research in Immunology and Cancer, Université de Montréal, Montreal, QC, Canada.
Daniel Alexander Jimenez CruzBioinformatics Platform, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Thupten TseringCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Qianqian ZhouCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Aurélie Fuentes-RodriguezDepartment of Ophthalmology and Otorhinolaryngology-Cervico-Facial Surgery, Faculty of Medicine, Université Laval, Quebec City, QC, Canada.
Alexandra BartolomucciCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Alicia GoyenecheCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Solange LandrevilleDepartment of Ophthalmology and Otorhinolaryngology-Cervico-Facial Surgery, Faculty of Medicine, Université Laval, Quebec City, QC, Canada.
Miguel N BurnierCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada.
Julia V BurnierCancer Research Program, Research Institute of the McGill University Health Centre, Montreal, QC, Canada. Julia.burnier@mcgill.ca.ORCID 0000-0002-2184-2157

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundUveal melanoma (UM) is the most common intraocular tumor in adults, arises either de novo from normal choroidal melanocytes (NCMs) or from pre-existing nevi that stem from NCMs and are thought to harbor UM-initiating mutations, most commonly in GNAQ or GNA11. However, there are no commercially available NCM cell lines, nor is there a detailed protocol for developing an oncogene-mutated CM line (MutCM) to study UM development. This study aimed to establish and characterize premalignant CM models from human donor eyes to recapitulate the cell populations at the origin of UM.

resultsGiven the precious value of human donor eyes for studying multiple ocular cell types, we validated a co-isolation protocol of both human NCMs and retinal pigment epithelial (RPE) cells from a single eye. To this end, NCMs and RPE cells were sequentially isolated from 20 donors, with success rates of 95% and 75%, respectively. MutCMs were generated from 10 donors using GNAQ

conclusionsWe successfully isolated and established NCM, RPE, and MutCM cell lines. We describe efficient methods for the isolation and growth of NCMs and report their phenotypic, proteomic, and transcriptomic characteristics, which will facilitate the investigation of UM development and progression. The co-isolated RPE cells could benefit research on other ocular pathologies, such as age-related macular degeneration.

Indexed as

Cell SeparationMelanocytesMelanomaMutationOncogenesUveal NeoplasmsHumansRetinal Pigment EpitheliumUveal MelanomaChoroidal melanocytesGNAQ mutationHuman donor eyesIn vitro modelsProteomicsUveal melanoma

Identifiers

PMID39838458
PMCPMC11752652

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.